4.3 Article

HUMAN HEALTH HAZARDS OF VETERINARY MEDICATIONS: INFORMATION FOR EMERGENCY DEPARTMENTS

期刊

JOURNAL OF EMERGENCY MEDICINE
卷 40, 期 2, 页码 198-207

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jemermed.2009.09.026

关键词

Veterinary Medications; Human health hazards; emergency department; One Medicine; carfentanil; clenbuterol (Ventipulmin); ketamine; tilmicosin (Micotil); testosterone/estradiol (Component E-H and Synovex H); dinoprost (Lutalyse/Prostamate); cloprostenol (Estromate/EstroPlan)

向作者/读者索取更多资源

Background: There are over 5000 approved prescription and over-the-counter medications, as well as vaccines, with labeled indications for veterinary patients. Of these, there are several products that have significant human health hazards upon accidental or intentional exposure or ingestion in humans: carfentanil, clenbuterol (Ventipulmin), ketamine, tilmicosin (Micotil), testosterone/estradiol (Component E-H and Synovex H), dinoprost (Lutalyse/Prostamate), and cloprostenol (Estromate/EstroPlan). The hazards range from mild to life-threatening in terms of severity, and include bronchospasm, central nervous system stimulation, induction of miscarriage, and sudden death. Objective: To report medication descriptions, human toxicity information, and medical management for the emergent care of patients who may have had exposure to veterinary medications when they present to an emergency department (ED). Discussion: The intended use of this article is to inform and support ED personnel, drug information centers, and poison control centers on veterinary medication hazards. Conclusion: There is a need for increased awareness of the potential hazards of veterinary medications within human medicine circles. Timely reporting of veterinary medication hazards and their medical management may help to prepare the human medical community to deal with such exposures or abuses when time is of the essence. (C) 2011 Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据